Tolerability of a modern antihypertensive agent: candesartan cilexetil O.K. Andersson Pages: s054 - s058
The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression Y. NishimuraT. XuJ.M. Saavedra Pages: s063 - s068
Antihypertensive therapy before, during, and after stroke Z.S. MzimbaD.G. BeeversG.Y.H. Lip Pages: s059 - s062
Hypertension and stroke – rationale behind the ACCESS trial J. SchraderM. RöthemeyerK. Kollmann Pages: s069 - s078
Hypertension and the renin-angiotensin system – evidence from genetic and transgenic studies L. RothermundM. Paul Pages: s001 - s006
Interactions between the renin-angiotensin system (RAS) and the sympathetic system A. DendorferW. RaaschP. Dominiak Pages: s024 - s029
Diabetes – renal function – what are the special problems? E. RitzG. Miltenberger-MiltenyiI. Rychlik Pages: s125 - s130
Effects of candesartan cilexetil on glucose homeostasis P. Trenkwalderfor the Multicenter Study Group Pages: s140 - s144
Angiotensin II acts intracellularly in vascular smooth muscle cells H. HallerF.C. Luft Pages: s030 - s036
AT1 receptor blockade in experimental myocardial ischemia/reperfusion A. JalowyR. SchulzG. Heusch Pages: s085 - s091
Angiotensin II and coronary artery disease, congestive heart failure, and sudden cardiac death R. DietzR. von HarsdorfK.J. Osterziel Pages: s101 - s108
Interaction between Insulin and AT1 receptor. Relevance for hypertension and arteriosclerosis G. NickenigM. Böhm Pages: s135 - s139
Metabolic syndrome and hypertension: pathophysiology and molecular basis of insulin resistance D. Müller-WielandJ. KotzkaW. Krone Pages: s131 - s134
Myocardial angiotensin receptors in human hearts V. Regitz-ZagrosekJ. FielitzE. Fleck Pages: s037 - s042
Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction J. Holtz Pages: s092 - s100
